Feed SHMDW
Summary
25 / 100 · Bulios Score
Valuation 100Growth 0Profitability 7Quality 11Debt 0Stability 30
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 12% a year over the last 3 years.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (EUR)
20212022202320242025
Diluted EPS (EUR)
20212022202320242025
Revenue fell by 12% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Cash and short-term investments 1.57M €
Debt 131.6M €
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
- CHINA 38%
- UNITED STATES 30%
- Europe, Middle East, and Africa Excluding Germany 15%
- Asia Excluding China 11%
- GERMANY 6.2%
- Other 0.0%
CHINA brings in 38% of revenue.
Segments in detail